Search for Clinical Trial Results

Sponsored By

Sarcoidosis - 44 Studies Found

Status Study
Completed Study Name: Rituximab for Pulmonary Sarcoidosis
Condition: Sarcoidosis
Date: 2009-03-03
Interventions: Drug: Rituximab Rituximab will be administered by IV infusion at a dose of 1000 mg (1 g) on day 1 and 15
Recruiting Study Name: Worldwide Sarcoidosis Research Study
Condition: Sarcoidosis
Date: 2012-05-31
Interventions: Other: Survey Longitudinal surveys
Active, not recruiting Study Name: Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
Condition: Sarcoidosis
Date: 2013-04-10
Interventions:
  • Drug: Roflumilast Roflumilast
Withdrawn Study Name: Cardiac Sarcoidosis Response To Steroids Trial
Condition:
  • Cardiac Sarcoidosis
  • Sarcoidosis Date: 2010-09-27
    Interventions: Drug: Prednisone Prednisone 0.5 mg/Kg orally per day for 3 months
Recruiting Study Name: Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Condition: Sarcoidosis
Date: 2012-12-06
Completed Study Name: Trial of Antimycobacterial Therapy in Sarcoidosis
Condition: Sarcoidosis
Date: 2010-02-08
Interventions:
  • Drug: Antibiotic Regimen Levaq
Completed Study Name: A Study of Adalimumab to Treat Sarcoidosis of the Skin
Condition: Sarcoidosis
Date: 2006-01-06
Interventions: Drug: adalimumab Adalimumab 40 mg administered subcutaneously once weekly or placebo injection administe
Withdrawn Study Name: A Phase 2 Study With CC-220 in Skin Sarcoidosis
Condition: Sarcoidosis
Date: 2014-07-15
Interventions:
  • Drug: CC-220 0.3 mg Daily
  • Drug: CC-220 0.6
Completed Study Name: Impact of CCR5 Inhibition on Sarcoidosis Immunophenotypes
Condition: Sarcoidosis
Date: 2014-04-30
Interventions:
  • Drug: all subjects will receive maraviroc 300mg orally twice a day for 6 wee
Suspended Study Name: Stromal Gene Expression During Pulmonary Sarcoidosis
Condition: Sarcoidosis
Date: 2009-02-04
Next >>>